# PI Pembro in Combination With Stereotactic Body Radiotherapy for Liver Metastatic Colorectal Cancer

> **NCT02837263** · PHASE1 · COMPLETED · sponsor: **University of Wisconsin, Madison** · enrollment: 15 (actual)

## Conditions studied

- Colorectal Cancer
- Colorectal Adenocarcinoma
- Stage IVA Colorectal Cancer
- Stage IVB Colorectal Cancer
- Metastatic Carcinoma in the Liver

## Interventions

- **RADIATION:** Stereotactic body radiotherapy (SBRT)
- **DRUG:** Pembrolizumab

## Key facts

- **NCT ID:** NCT02837263
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08-11
- **Primary completion:** 2021-11-02
- **Final completion:** 2023-05-31
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2026-05-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02837263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02837263, "PI Pembro in Combination With Stereotactic Body Radiotherapy for Liver Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02837263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*